Standard Biotools (LAB) Share-based Compensation Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.13% |
| Dec 31, 2025 | 3.31% |
| Sep 30, 2025 | 11.58% |
| Jun 30, 2025 | 8.13% |
| Mar 31, 2025 | 27.75% |
| Dec 31, 2024 | 45.33% |
| Sep 30, 2024 | 8.95% |
| Jun 30, 2024 | 2.65% |
| Mar 31, 2024 | 38.59% |
| Dec 31, 2023 | -6.89% |
| Sep 30, 2023 | 8.01% |
| Jun 30, 2023 | 9.18% |
| Mar 31, 2023 | 12.50% |
| Dec 31, 2022 | -3.37% |
| Sep 30, 2022 | 14.12% |
| Jun 30, 2022 | 14.89% |
| Mar 31, 2022 | 10.57% |
| Sep 30, 2021 | 26.76% |
| Jun 30, 2021 | 14.74% |
| Mar 31, 2021 | -0.22% |
| Dec 31, 2020 | 0.71% |
| Sep 30, 2020 | 1.01% |
| Jun 30, 2020 | -4.76% |
| Mar 31, 2020 | -10.27% |
| Dec 31, 2019 | -29.88% |
| Mar 31, 2019 | -3.02% |
| Dec 31, 2018 | 23.10% |
| Sep 30, 2018 | -13.23% |
| Jun 30, 2018 | 3.38% |
| Dec 31, 2017 | 13.89% |
| Sep 30, 2017 | 18.35% |
| Jun 30, 2017 | 16.19% |
| Mar 31, 2017 | 22.14% |
| Dec 31, 2016 | 28.73% |
| Sep 30, 2016 | 38.64% |
| Jun 30, 2016 | 49.47% |
| Mar 31, 2016 | 36.31% |
| Dec 31, 2015 | 65.31% |
| Sep 30, 2015 | 58.06% |